Friday, June 19, 2026
🇺🇸 FDA
ASCO 2026 pharmaceutical event banner
← Back to Events
Tier 1 Global Networking: High ONCOLOGY CONCLUDED

ASCO 2026 — McCormick Place, Chicago, United States

The 2026 ASCO Annual Meeting is The Place to Be. Learn more about the sessions, speakers, and science that will be presented at this year's meeting below. Answer who/what/when/where for ASCO 2026 Program pdf with verified dates, location, and what B2B readers should watch. ASCO 2

McCormick Place, Chicago, United States June 5 – June 9, 2026
45,000+ Attendees
9 Presentations
7 Companies
7 Drugs
All Events

Presentation data updated Jun 5, 2026, 9:21 AM UTC

Nova Event Impact Score
59 /100
  • Media coverage 10/20
  • Speaker quality 20/20
  • Pipeline relevance 2/20
  • Historical influence 13/20
  • Company participation 14/20

Key Takeaways

Key Themes

oncologycongressPipeline announcementsPartnership deals

Key Companies

Gilead SciencesAmgenMerck & Co.Johnson & JohnsonPfizer

Key Drugs

pembrolizumabsotorasibsacituzumab tirumotecanamivantamabpumitamig

Key Markets

US Americas

Key Opportunities

Partnership dealsLicensing discussionsVendor selection
Best for
Oncology BD teams Clinical development leaders Investors & analysts

pembrolizumab at ASCO 2026

1 presentation

pembrolizumabKeytruda Drug profile linked when published in our directory.
LATE-BREAKER Jun 7

Updated overall survival data from the Phase III KEYNOTE-789 trial of pembrolizumab in non-small cell lung cancer

Merck & Co.$MRK pembrolizumab(Keytruda) Phase Iii Non-small cell lung cancer
Event presentation hub → Company at this event →
INVESTOR IMPACT: ★★★★★ 5/5